Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The menopause and the skeleton: key issues

J A Kanis1

  • 1University of Sheffield, UK.

Bailliere'S Clinical Obstetrics and Gynaecology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Burden of high fracture probability worldwide: secular increases 2010-2040.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015

Hormone replacement therapy (HRT) has a rationale for osteoporosis prevention at menopause, but its application is limited. Further research is needed to understand osteoporosis causes beyond menopause for effective prevention.

Area of Science:

  • Endocrinology and Metabolic Bone Diseases
  • Reproductive Medicine and Women's Health

Background:

  • Hormone replacement therapy (HRT) is considered for osteoporosis prevention around menopause.
  • Several factors limit the widespread application of HRT for osteoporosis management.
  • The role of menopause in osteoporosis may be overemphasized, with other factors influencing risk.

Purpose of the Study:

  • To evaluate the limitations of HRT for osteoporosis prevention in menopausal women.
  • To explore factors contributing to geographical variations and increasing incidence of osteoporosis.
  • To identify the etiology of osteoporosis to develop effective preventive strategies.

Main Methods:

  • Review of existing literature on HRT efficacy and limitations for osteoporosis.
  • Analysis of factors influencing osteoporosis prevalence and hip fracture risk.

Related Experiment Videos

  • Hypothesis generation regarding the role of lifestyle factors, such as physical activity.

    • Main Results:

    • Long-term efficacy of HRT initiated at menopause requires further investigation.
    • Benefits and risks of HRT are primarily extraskeletal, complicating its use for osteoporosis.
    • Osteoporosis incidence is increasing in both men and women, independent of gonadal status.

    Conclusions:

    • The current application of HRT for osteoporosis is limited by efficacy and risk considerations.
    • The etiology of increasing osteoporosis rates needs elucidation, with decreased physical activity as a potential factor.
    • Understanding the causes of osteoporosis is crucial for developing targeted preventive strategies.